EUVIMEDEUVIMED entdecken
Crossref

Isobaric Ropivacaine (0.75%) With Or Without Nalbuphine for Spinal Anaesthesia in Endoscopic Urological Surgery: A Prospective, Randomized, Controlled, Double Blind Study

Neha Rathore, Kunal Chauhan, Anil Kumar Bhiwal, Alka Chhabra, Neelesh Bhatnagar, Jay Mohanbhai Patel

International Journal of Current Pharmaceutical Review and Research · 13.05.2026 · 18 (05)

DOI: 10.25258/ijcpr.18.5.38 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 13.05.2026. Verfasst von Neha Rathore und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims and Objective: Spinal anesthesia is a safe and reliable technique for urological surgery, providing excellent analgesia and muscle relaxation. Ropivacaine is a long-acting anesthetic drug with a greater margin of safety compared to bupivacaine. Nalbuphine is a mixed agonist-antagonist opioid that provides analgesia and sedation without significant side effects. The aim of this study was to evaluate the effect of intrathecal nalbuphine on sensory and motor block characteristics, prolongation of postoperative analgesia and side effects when used as an adjuvant with isobaric 0.75% ropivacaine in spinal anesthesia. Materials and Method: This prospective, randomized, controlled, double-blind study included 60 patients undergoing elective endoscopic urological surgery under spinal anesthesia. Patients were randomly allocated into two groups: Group I received isobaric ropivacaine (0.75%) 2.5 ml with normal saline 1 ml, while Group II received isobaric ropivacaine (0.75%) 2.5 ml with nalbuphine (0.8mg). Sensory and motor block characteristics, postoperative analgesia, and side effects were assessed.

Results

The mean onset time of sensory block in group II was found to be significantly less than in group I, (p = 0.006.). The mean onset time of motor block and time to complete motor block was significantly earlier in Group II as compared to Group I (p=0.0277 and p=0.046 respectively). The time to first rescue analgesic was significantly longer in Group II (p=0.0054), and the number of doses required in 24 hours was significantly lower in Group II (p=0.0018).

Conclusion

The addition of nalbuphine to isobaric ropivacaine (0.75%) for spinal anesthesia in endoscopic urological surgery improves sensory and motor block characteristics, prolongs postoperative analgesia, and reduces the requirement for rescue analgesics.

Zitieren

APA

Rathore, N., Chauhan, K., Bhiwal, A. K., Chhabra, A., Bhatnagar, N., & Patel, J. M. (2026). Isobaric Ropivacaine (0.75%) With Or Without Nalbuphine for Spinal Anaesthesia in Endoscopic Urological Surgery: A Prospective, Randomized, Controlled, Double Blind Study. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.38

Vancouver

Rathore N, Chauhan K, Bhiwal AK, Chhabra A, Bhatnagar N, Patel JM. Isobaric Ropivacaine (0.75%) With Or Without Nalbuphine for Spinal Anaesthesia in Endoscopic Urological Surgery: A Prospective, Randomized, Controlled, Double Blind Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.38

BibTeX
@article{Rathore2026,
  author = {Rathore, Neha and Chauhan, Kunal and Bhiwal, Anil Kumar and Chhabra, Alka and Bhatnagar, Neelesh and Patel, Jay Mohanbhai},
  title = {Isobaric Ropivacaine (0.75%) With Or Without Nalbuphine for Spinal Anaesthesia in Endoscopic Urological Surgery: A Prospective, Randomized, Controlled, Double Blind Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {05},
  doi = {10.25258/ijcpr.18.5.38}
}
Kostenlos starten →